Healthcare Spending Contracted Amid Subsidy Lapses
Healthcare and life sciences operators should prepare for lower demand following a 2.8% dip in business spending commitments.
Updated on Oct. 9, 2026 in Healthcare
Live Poll
Do you feel business spending is currently growing or weakening in the U.S. economy?
Coupa reported a 2.8% decline in healthcare and life sciences spending between February and June 2026. This contraction, driven by the lapse of Affordable Care Act subsidies and a 34% drop in NIH grants, highlights cooling activity in the sector.
Why it matters
The decline in spending reflects a tightening of capital and public funding, which constrains operational budgets and research output. Operators must adjust to these reduced inflows as the sector faces broad economic shifts.
The index tracks $10.5 trillion in transactions across a baseline of 100 established in January 2022. While healthcare spending fell 2.8%, other sectors showed varying activity, such as a 6.5% rise in high-tech commitments.
The players
Coupa
A global provider of business spend management software that aggregates data from trillions in B2B transactions.
National Institutes of Health
The primary federal agency responsible for biomedical and public health research through grant programs.
The details
The Business Spend Index tracks industry health through approved purchase orders, signed contracts, and executed renewals before they reach official economic reports. The downturn in healthcare spending follows the expiration of Affordable Care Act subsidies and a significant pullback in federal research funding. These indicators provide early warning signs for suppliers and service providers who rely on healthcare operational budgets.
Timeline
January 2022: Index baseline set at 100.
February 2026: Healthcare spending decline began; manufacturing index reached 156.5.
June 2026: Healthcare spending contraction period concluded.
April 2026: Financial services spending reached a peak index reading.
July 2026: Financial services index reading hit 115.4.
Market Landscape
This decline follows the lapse of Affordable Care Act subsidies, which previously underpinned consistent market demand. It mirrors broader volatility in business spending as firms re-evaluate contracts in a higher-cost environment.
Operators in the healthcare supply chain should account for reduced contract renewals and a potential stagnation in R&D-linked purchases. Review your exposure to NIH-funded clients and assess whether your current pipeline reflects this shift in federal and subsidized spending.
The takeaway
The decline in spending signals a contraction in the liquidity previously fueled by public subsidies and grants. Monitor the renewal rates of your primary healthcare contracts to determine if this cooling trend is impacting your specific vendor relationships.
Further reading
For broader trends impacting the industry, see our analysis of Healthcare.
Source note: This article includes information reported by CFOtech US.
Live Poll
Do you feel business spending is currently growing or weakening in the U.S. economy?
